Linda Rendle
Analyst · UBS Financial
Thanks, Anna. I'll go through these. And if I miss anything, please come back to me. Innovation, that has been largely very successful in this back half. So despite everything that's going on, our innovation execution, and I'm going to put Litter to the side for a moment, and I'll touch on that again, has been great. So our largest innovation with Clorox PURE, which is our allergen platform, has gone very well. We got early wins on distribution. We were online early. We're getting great reviews. Retailers are very excited and they're excited for the next round that we have coming at the beginning of fiscal year '27. We'll bring them some new benefits in this category. But on that, we got preferred shelf placement. And these are new sections of the store for us, and retailers are partnering with us to ensure we can get this in front of consumers. So feeling terrific about that big innovation platform, its execution and the results, which are at this point from a velocity perspective, above expectations. I'd also note that the other innovations we have in Cleaning, including the expansion of our Scentiva line continue to do really well. We launched a new flavor in Cherry Blossom and that has been our #1 scent, and we're expanding that scent into different forms. But that's a place where, as I talked about, consumers are continuing to willing to pay for a premium experience and joy and scent fit in that bucket and Scentiva continues to personify that. I'd also call out our food launches, which we believe are off to a good start and our Glad line where we have a new absorbent layer in our trash bag, we continue to feel good about the distribution and the plans for that as well as new scent. So generally, innovation, very strong execution and strong performance. Litter, again, early days, and this was a hard conversion. So I would note it's not unexpected where we are, but we just have not proven yet that it is exactly what it needs to be, and we are making the adjustments to the plan. I feel good about the fact that we're offering a better value. The claims are better. The packaging is better. Our digital execution is much stronger, and we're seeing very strong digital pickup on Fresh Step, but we don't have yet the whole thing in market yet to see exactly where we need to make adjustments. The places we do know we need to make adjustments, we are with retailers right now doing that. So I'd call that out as the one place in innovation that is behind our expectation with everything else at or above. And then on -- I'll go to your next question, as long as I've covered innovation sufficiently for you. I'll start with private label. And I think I mentioned in one of my comments that private label shares have been flat over the majority of our categories. It's basically stabilized. We're watching it really carefully because we have seen ticks up in certain time periods as retailers promoted or and bring in a new item. But generally, consumers continue to want brands, and they continue to want value overall, not just the lowest price. There are places where we've seen a bit more pickup in private label. Brita would be one. We're watching that one carefully. We've seen that trend over time. And as we continue to launch innovation, we end up getting some of that share back, but that's a place we're watching carefully. And then I'd say we're watching carefully any other place where retailers are leaning in and making investments. But overall, private label just hasn't had the impact that many would have expected. And I know many of you are asking questions about that. We've continued to see it play the role that it normally does, which is offering a low price for those consumers who need it. And then on GOJO on the long-term algorithm, certainly, GOJO is a strong step to delivering our overall algorithm, which we remain committed to. But also what is also very important is that our categories get back to normalized levels in order for us to deliver that. So because it's accretive from a growth perspective, we see that playing a role in '27 and beyond. And of course, most importantly, we're focused on getting our core categories back up to what they were before in low mid-single digits.